AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Many households succeed with zero based budgeting because it ties every expense to a purpose, preventing ambiguity and overspending.
25,253 articlesAbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Johnson Johnson walking away from a GLP-1 obesity obsession signals a shift to a diversified, potentially more resili...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
DBA closed $68 million for its second venture fund on Feb. 18, 2026, signaling sustained appetite for crypto infrastr...
OpenAI says shares Anthropic’s red lines on how the military can use AI, signaling a rare cross-firm consensus that c...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
Lenders unveil data-driven loan terms tied to connected design, procurement, and field data. The move marks the next ...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
Stocks ride to record highs while bond yields climb. This article explains why treasury yields soaring that's driving...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...